Nutex Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	981.2	479.95	247.65	219.29	331.53	274.03
Revenue Growth (YoY)	236.03%	93.80%	12.93%	-33.85%	20.98%	182.34%
Cost of Revenue	420.8	264.72	195.28	190.74	144.59	104.56
Gross Profit	560.39	215.23	52.37	28.55	186.94	169.47
Selling, General & Admin	46.58	41.92	33.23	19.81	5.46	10.4
Operating Expenses	201.41	77.45	53.66	33.13	13.12	16.29
Operating Income	358.98	137.78	-1.29	-4.58	173.82	153.17
Interest Expense	-22.3	-19.93	-16.32	-12.49	-6.2	-6.43
Other Non Operating Income (Expenses)	-9.15	-0.94	-0.4	-0.56	-0.12	-1
EBT Excluding Unusual Items	327.53	116.91	-18.01	-17.63	167.5	145.74
Merger & Restructuring Charges	-3.89	-3.89	-29.34	-3.89	-3.55	-
Impairment of Goodwill	-0	-3.2	-1.14	-398.14	-	-
Other Unusual Items	-	-	-	-	5.55	-
Pretax Income	327.54	109.83	-48.49	-419.65	169.49	145.74
Income Tax Expense	64.29	15.02	-5.07	13.09	0.97	0.18
Earnings From Continuing Operations	263.25	94.81	-43.42	-432.74	168.53	145.56
Minority Interest in Earnings	-142.68	-42.71	-2.36	7.96	-35.93	-39.59
Net Income	120.57	52.1	-45.79	-424.78	132.59	105.97
Net Income to Common	120.57	52.1	-45.79	-424.78	132.59	105.97
Net Income Growth	-	-	-	-	25.12%	406.47%
Shares Outstanding (Basic)	6	5	4	4	4	4
Shares Outstanding (Diluted)	7	5	4	4	4	4
Shares Change (YoY)	40.46%	24.57%	4.15%	7.10%	-	-
EPS (Basic)	20.25	10.23	-10.39	-100.36	33.55	26.81
EPS (Diluted)	17.98	9.69	-10.39	-100.36	33.00	26.81
EPS Growth	-	-	-	-	23.07%	-
Free Cash Flow	174.28	20.85	-8.24	35.97	136.51	25.48
Free Cash Flow Per Share	25.58	3.80	-1.87	8.50	34.54	6.45
Gross Margin	57.11%	44.84%	21.14%	13.02%	56.39%	61.84%
Operating Margin	36.59%	28.71%	-0.52%	-2.09%	52.43%	55.90%
Profit Margin	12.29%	10.85%	-18.49%	-193.70%	39.99%	38.67%
Free Cash Flow Margin	17.76%	4.34%	-3.33%	16.41%	41.17%	9.30%
EBITDA	379.61	156.75	16.3	8.55	181.48	159.07
EBITDA Margin	38.69%	32.66%	6.58%	3.90%	54.74%	58.05%
D&A For EBITDA	20.62	18.97	17.59	13.13	7.66	5.9
EBIT	358.98	137.78	-1.29	-4.58	173.82	153.17
EBIT Margin	36.59%	28.71%	-0.52%	-2.09%	52.43%	55.90%
Effective Tax Rate	19.63%	13.68%	-	-	0.57%	0.12%
Revenue as Reported	981.2	479.95	247.65	219.29	331.53	274.03

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q